Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

China · Delayed Price · Currency is CNY

25.96

-0.48 (-1.82%)

Sep 10, 2026, 12:14 PM CST

Shandong Wit Dyne Health Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Revenue	1,906	2,228	2,134	2,484	2,341	2,027
Revenue Growth	-11.36%	4.40%	-14.08%	6.11%	15.49%	11.32%
Gross Profit	1,585	1,889	1,791	2,145	1,838	1,397
Operating Income	875.45	1,177	1,149	1,256	1,133	776.89
Net Income	421.03	535.08	515.59	585.26	526.86	380.26
Earnings Per Share	1.79	2.28	2.20	2.50	2.25	1.62
EPS Growth	-19.22%	3.64%	-12.00%	11.11%	38.89%	30.64%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Products	2,215
Other	32.99
Offset	-21.72
Total	2,226

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash & Investments	2,205	3,264	3,079	3,262	2,794	1,945
Total Debt	-	-	-	-	7.89	-
Net Cash (Debt)	2,205	3,264	3,079	3,262	2,786	1,945
Net Cash Growth	-20.37%	6.01%	-5.62%	17.10%	43.22%	30.36%
Net Cash Per Share	9.40	13.91	13.14	13.93	11.90	8.29

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Operating Cash Flow	515.74	1,272	929.61	1,175	1,196	755.85
Capital Expenditures	-16.92	-48.32	-43.64	-50.61	-89.68	-120.34
Free Cash Flow	498.82	1,223	885.97	1,124	1,107	635.51
Free Cash Flow Growth	-55.73%	38.06%	-21.18%	1.57%	74.15%	0.27%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Gross Margin	83.15%	84.75%	83.90%	86.35%	78.53%	68.90%
Operating Margin	45.92%	52.81%	53.81%	50.57%	48.41%	38.32%
Pretax Margin	48.49%	54.16%	55.20%	53.35%	49.52%	40.51%
Profit Margin	22.09%	24.01%	24.15%	23.56%	22.50%	18.76%
FCF Margin	26.17%	54.89%	41.51%	45.25%	47.27%	31.35%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Dividend Per Share	2.500	2.500	2.500	2.000	0.800	0.800
Dividend Per Share Growth	0%	0%	25.00%	150.00%	0%	128.57%
Dividend Yield	9.95%	8.14%	10.33%	8.67%	2.26%	3.46%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
PE Ratio	14.74	14.47	12.81	11.60	20.24	18.77
Forward PE	-	13.39	12.55	10.50	15.95	14.64
P/FCF Ratio	12.42	6.33	7.45	6.04	9.63	11.23
PS Ratio	3.25	3.47	3.09	2.73	4.55	3.52